This is a continuation of the post “The drug development process – Part 1”
Clinical trial development must follow a strict and comprehensive process and there are different objectives and focuses for each phase. Generally, phase I trials assess the toxicity of a drug, while phase II focuses on in-depth study of the drugs activity with the chosen condition or indication. Phase III aims to prove the drugs efficacy (efficiency) as a treatment or cure for a condition. However, the safety of the drug is a common consideration throughout the entire process.
As we’ve said before, the drug development process is long and complex. There is always a measure of anticipation from the market and patients, but there is also an overwhelming amount of work involved. Ultimately the lengthy processes and protocols are there for two important reasons: to ensure safety and effectively demonstrate the drugs effectiveness and efficiency (efficacy).
